We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MSC:NYSEStudio City International Holdings Limited Analysis

Data as of 2026-07-01 - not real-time

$1.85

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Technical indicators show MSC trading at $1.85, firmly below its 20‑day SMA (≈$2.09), 50‑day SMA (≈$2.31) and 200‑day SMA (≈$3.14). The 14‑day RSI sits at ~36, the MACD line is negative and diverging from its signal, and volume has been on a declining trend, all pointing to continued bearish pressure. Volatility is extreme at roughly 73% over the past 30 days and the stock’s beta of –1.12 suggests an inverse move to the broader market, further amplifying downside risk.
On the fundamentals side, MSC posted a 9.3% revenue increase but still generated a negative profit margin (‑5.6%) and a trailing EPS of –$0.20. The balance sheet is heavily leveraged with a debt‑to‑equity ratio of 368, cash of $86.8 M versus debt of $2.03 B, and a ROE of –7.5%. While the price‑to‑book (0.71) and price‑to‑sales (0.50) ratios appear cheap, the lack of earnings, zero dividend and high leverage make the valuation fragile. The market sentiment is in “Extreme Greed” territory, yet the stock suffers from low liquidity (average daily volume ~10k shares) and significant regulatory exposure in Macau’s casino sector.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major moving averages
  • Negative earnings and heavy debt load
  • Decreasing volume and high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Valuation appears cheap relative to book value
  • Potential recovery in Macau tourism could improve cash flows
  • Continued leverage and uncertain regulatory environment

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Structural debt overhang limits upside
  • Long‑term asset base offers a floor price
  • Persistent sector and geographic risks may impede recovery

Key Metrics & Analysis

Financial Health

Revenue Growth9.30%
Profit Margin-5.63%
P/E Ratio-18.5
ROE-7.46%
ROA1.88%
Debt/Equity368.29
P/B Ratio0.7

Technical Analysis

TrendBearish
RSI35.9
Support$1.80
Resistance$2.88
MA 20$2.09
MA 50$2.31
MA 200$3.14
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-1.12
Volatility72.88%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.